Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) Sort ascending | Title |
|---|---|---|---|
| PAR-22-118 | June 7, 2024 | R25 | International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) |
| PAR-23-137 | June 7, 2025 | R25 | NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
| PAR-22-195 | September 8, 2025 | R25 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed) |
| PAR-22-224 | May 26, 2025 | R25 | NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
| PAR-23-114 | January 17, 2026 | R25 | Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) |
| RFA-NS-24-014 | February 11, 2025 | R25 | NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed) |
| PAR-22-247 | May 26, 2025 | R24 | Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) |
| RFA-MH-25-110 | June 25, 2026 | R24 | BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
| PAR-23-318 | March 21, 2026 | R21/R33 | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
| NOT-OD-23-166 | May 8, 2026 | R21,R15,R01,R34,K25,K99/R00,K01,R03,P01,K08,K23 | Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations |
| NOT-HD-23-003 | September 8, 2024 | R21,R03,R01 | Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals |
| NOT-OD-22-178 | May 8, 2025 | R21,R01,UG3/UH3,R61/R33,R34,R03 | Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
| NOT-OD-22-179 | May 8, 2025 | R21,R01,R61/R33,UG3/UH3,R34,U01 | Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
| NOT-OD-22-167 | October 5, 2025 | R21,R01,R34,UG3/UH3 | Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes |
| NOT-ES-22-006 | May 8, 2025 | R21,F31,D43,K01,R03,K43,K99/R00,U01,U19,R01,F32,K23,F30,R21/R33 | Notice of Special Interest (NOSI): Climate Change and Health |
| RFA-HD-25-009 | July 25, 2024 | R21 | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
| NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
| PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
| RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
| PAR-23-296 | September 8, 2026 | R21 | Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed) |
BACK TO TOP